Intravenous resveratrol administration suppress trigeminal WDR neuronal excitability.
Suppressive effect of resveratrol was dose-dependent and reversible manner.
Magnitude of inhibition was significantly greater for noxious than non-noxious stimulation.
Resveratrol contributes to CAM therapeutic agents for trigeminal nociception without side effect.